Astellas recently introduced Fezolinetant, a breakthrough treatment for menopause symptoms. Prior to the product launch, Astellas aimed to educate doctors on the underlying cause of hot flashes and night sweats—recently discovered science revealing that these symptoms result from neuronal misfiring. This knowledge was crucial in highlighting the innovation behind the new treatment.